Equine herpesvirus type 1 modified live virus vaccines:quo vaditis?
- 1 February 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 5 (1) , 119-131
Abstract
Infections of horses with equine herpesvirus type 1 (EHV-1) have garnered new attention over the last few years. Devastating outbreaks occurring worldwide, primarily of the neurologic form of the disease, have resulted in a reassessment of the control strategies, and particularly the prophylactic measures, that are necessary to keep the infection and spread of disease in check. Most of the available EHV-1 vaccines are based on preparations of inactivated virus, which are applied monovalently for prevention of EHV-1-caused abortion in pregnant mares or as part of multivalent vaccines to prevent respiratory disease. Despite the importance of an induction of cytotoxic immune responses for protection against EHV-1-induced disease, only two modified live virus vaccine preparations, which are both based on the avirulent EHV-1 strain RacH and were developed more than 40 years ago, are commercially available. Current efforts focus on exploiting the available infectious bacterial artificial chromosome clones of various EHV-1 strains to engineer a new generation of modified live virus vaccines. Both more efficient and long-lasting anti-EHV-1 immunity and delivery of immunogens of other pathogens are attempted and within immediate reach. The improvement of modified live virus vaccines will likely be a major focus of research in the future, and will hopefully help to more completely protect horses against one of the most important and devastating viral diseases.Keywords
This publication has 78 references indexed in Scilit:
- Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foalsVeterinary Microbiology, 1999
- Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997Veterinary Microbiology, 1999
- Equid Herpesvirus-Induced Associated with Lymphoid Circulating Immunosuppression is Cells and Not Soluble FactorsViral Immunology, 1999
- Seroprevalence of equine herpesvirus 1 in Thoroughbred foals before and after weaningAustralian Veterinary Journal, 1998
- Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse modelVirus Research, 1996
- Distribution of Equid herpesvirus‐1 (EHV‐1) in respiratory tract associated lymphoid tissue: implications for cellular immunityEquine Veterinary Journal, 1994
- Distribution of Equid herpesvirus‐1 (EHV‐1) in the respiratory tract of ponies: implications for vaccination strategiesEquine Veterinary Journal, 1994
- Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissuesJournal of General Virology, 1992
- Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: Equine strokeArchives of Virology, 1986
- Pathological observations on an outbreak of paralysis in broodmaresEquine Veterinary Journal, 1980